Linz, Valerie C.; Battista, Marco J.; Jakel, Joerg et al.
Management of gestational trophoblastic diseaseONKOLOGE. Bd. 27. H. 9. 2021 S. 941-952
Valerio, Luca; Pleming, William; Pecci, Alessandro et al.
Management of Lemierre SyndromeMINERVA MEDICA. Bd. 112. H. 6. 2021 S. 726-739
Klimek, Ludger; Jutel, Marek; Bousquet, Jean et al.
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperALLERGY. Bd. 76. H. 3. 2021 S. 677-688
Julian Wangler, JW; Michael Jansky, MJ
Management somatoformer Störungen – Herausforderungen für die Arzt-Patient-Beziehung.Doctors Today. Bd. 1. H. 10. 2021 S. 28-32
Kaatsch, Peter; Byrne, Julianne; Grabow, Desiree
Managing a Pan-European Consortium on Late Effects among Long-Term Survivors of Childhood and Adolescent Cancer-The PanCareLIFE ProjectINTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. Bd. 18. H. 8. 2021
Shavlokhova, Veronika; Goeppert, Benjamin; Gaida, Matthias M. et al.
Mandibular Brown Tumor as a Result of Secondary Hyperparathyroidism: A Case Report with 5 Years Follow-Up and Review of the LiteratureINTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. Bd. 18. H. 14. 2021
Nef, Holger M.; Achenbach, Stephan; Birkemeyer, Ralf et al.
Manual of the working group on interventional cardiology (AGIK) of the German Cardiac Society (DGK) Part 2: "Performance of percutaneous coronary interventions"KARDIOLOGE. Bd. 15. H. 6. 2021 S. 542-584
Nef, Holger M.; Achenbach, Stephan; Birkemeyer, Ralf et al.
Manual of the working on interventional cardiology (AGIK) of the German Cardiac Society (DGK) Part 1: Performance of diagnostic cardiac catheterizationKARDIOLOGE. Bd. 15. H. 4. 2021 S. 370-403
Hagendorff, Andreas; Helfen, Andreas; Flachskampf, Frank A. et al.
Manual on indications and performance of specific echocardiographic applicationsKARDIOLOGE. Bd. 15. H. 6. 2021 S. 595-641
Catenacci, Daniel V. T.; Rosales, Minori Koshiji; Chung, Hyun Cheol et al.
Margetuximab (M) combined with anti-PD-1 (retifanlimab) or anti-PD-1/LAG-3 (tebotelimab) plus /- chemotherapy (CTX) in first-line therapy of advanced/metastatic HER2+gastroesophageal junction (GEJ) or gastric cancer (GC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021